MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A

American Journal of Cancer Research

Volumn 5, Issue 9, 2015, Pages 2719-2729

  Wang, Biyun ^a   Yang, Ziang ^b   Wang, Hong ^b   Cao, Zhigang ^a   Zhao, Yannan ^a   Gong, Chengcheng ^a   Ma, Lijie ^c   Wang, Xiaoxiao ^b   Hu, Xichun ^a   Chen, She ^b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

breast cancer; miR 320a; RAB11A

Indexed keywords

MICRORNA; MICRORNA 320A; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER INHIBITION; CELL CYCLE ARREST; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MIGRATION INHIBITION; MITOSIS INHIBITION; MOUSE; NONHUMAN; RAB11A GENE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

EID: 85006190123     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. van Schooneveld E, Wildiers H, Vergote I, Vermeulen PB, Dirix LY and Van Laere SJ. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res 2015; 17: 21.
3. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S and Senkus E. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol 2012; 23 Suppl 7: vii11-19.
4. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215- 233.
5. Shukla GC, Singh J and Barik S. MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol 2011; 3: 83-92.
6. Wang D, Qiu C, Zhang H, Wang J, Cui Q and Yin Y. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One 2010; 5: e13067.
7. Yang H, Yu J, Wang L, Ding D, Zhang L, Chu C, Chen Q, Xu Z, Zou Q and Liu X. miR-320a is an independent prognostic biomarker for invasive breast cancer. Oncol Lett 2014; 8: 1043-1050.
8. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009; 10: 513-525.
9. Kelly EE, Horgan CP and McCaffrey MW. Rab11 proteins in health and disease. Biochem Soc Trans 2012; 40: 1360-1367.
10. Palmieri D, Bouadis A, Ronchetti R, Merino MJ and Steeg PS. Rab11a differentially modulates epidermal growth factor-induced proliferation and motility in immortal breast cells. Breast Cancer Res Treat 2006; 100: 127-137.
11. Li L, Luo J, Wang B, Wang D, Xie X, Yuan L, Guo J, Xi S, Gao J, Lin X, Kong Y, Xu X, Tang H and Liu M. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer 2013; 12: 163.
12. Schneider JG, Alosi JA, McDonald DE and McFadden DW. Pterostilbene inhibits lung cancer through induction of apoptosis. J Surg Res 2010; 161: 18-22.
13. Morrow AA, Alipour MA, Bridges D, Yao Z, Saltiel AR and Lee JM. The lipid kinase PI4KIIIbeta is highly expressed in breast tumors and activates Akt in cooperation with Rab11a. Mol Cancer Res 2014; 12: 1492- 1508.
14. Wang V and Wu W. MicroRNA-based therapeutics for cancer. Bio Drugs 2009; 23: 15-23.
15. Tang J, Ahmad A and Sarkar FH. The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci 2012; 13: 13414- 13437.
16. O'Day E and Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010; 12: 201.
17. Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P, Zhang Q, Dong L and Dong J. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. Oncol Rep 2012; 27: 685-694.
18. Zhao H, Dong T, Zhou H, Wang L, Huang A, Feng B, Quan Y, Jin R, Zhang W, Sun J, Zhang D and Zheng M. miR-320a suppresses colorectal cancer progression by targeting Rac1. Carcinogenesis 2014; 35: 886-895.
19. Qi X, Li J, Zhou C, Lv C and Tian M. MicroRNA- 320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma. FEBS Lett 2014; 588: 3732-3738.
20. He DX, Gu XT, Jiang L, Jin J and Ma X. A methylation- based regulatory network for microRNA 320a in chemoresistant breast cancer. Mol Pharmacol 2014; 86: 536-547.
21. Lu M, Ding K, Zhang G, Yin M, Yao G, Tian H, Lian J, Liu L, Liang M, Zhu T and Sun F. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRgamma. Sci Rep 2015; 5: 8735.
22. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, Gray JW and Mills GB. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004; 10: 1251-1256.
23. Horgan CP and McCaffrey MW. The dynamic Rab11-FIPs. Biochem Soc Trans 2009; 37: 1032-1036.
24. Peden AA, Schonteich E, Chun J, Junutula JR, Scheller RH and Prekeris R. The RCP-Rab11 complex regulates endocytic protein sorting. Mol Biol Cell 2004; 15: 3530-3541.
25. Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyries S, Adelaide J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C and Chaffanet M. Comprehensive profiling of 8p11- 12 amplification in breast cancer. Mol Cancer Res 2005; 3: 655-667.
26. Caswell PT, Chan M, Lindsay AJ, McCaffrey MW, Boettiger D and Norman JC. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J Cell Biol 2008; 183: 143-155.
27. Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY, Leong WY, Chan YS, Palanisamy N, Liu ET, Karuturi KM, Lim B and Miller LD. RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest 2009; 119: 2171-2183.